Join the club for FREE to access the whole archive and other member benefits.

Marco Quarta

Co-Founder CEO at Rubedo Life Sciences

Following a Masters degree in Biotechnology, a PhD in Neuroscience, and post-doctoral training in Stem Cells and Regenerative Medicine, he then led a team at Stanford University focused on translational medical research in the Department of Neurology and Neurological Sciences. Previously, he did a post doc at Stanford with his mentor, Prof. Thomas Rando, a world leader in the field of Stem Cells and Aging Studies. Marco Quarta is authors of several scientific publications in top tier journals (such as Nature, Nature Biotechnology, Cell Stem Cell, Nature Communications), and he is an inventor on U.S. patents.

Visit website: https://www.rubedolife.com/marco-quarta/

 marco4quarta

See also: Company Rubedo Life Sciences - Extending Health Span and Reverting Age-Related Diseases.

Marco Quarta is also referenced in the following:

Age-Related Disease Therapeutics Summit

31-May-2023 to 02-Jun-2023

Event about aging and aging related diseases organized by Hanson Wade

ARDD 2022 - 9th Aging Research and Drug Discovery Meeting

29-Aug-2022 to 02-Sep-2022

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

ARDD 2023 - 10th Aging Research & Drug Discovery Meeting

28-Aug-2023 to 01-Sep-2023

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

CULS Webinar: Marco Quarta

17-Feb-2022

Online webinar by Cambridge University Longevity Society with Marco Quarta, Co-Founder & CEO of Rubedo Life Sciences as speaker

Global Healthspan Summit 2023

29-Nov-2023 to 30-Nov-2023

Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)

Marco Quarta Blog Posts

Highlights of Ending Age-Related Diseases 2020
10-Sep-2020

Highlights of Ending Age-Related Diseases 2020

Key points from 20 presentations from world-leading researchers

Marco Quarta News

Reason reports back from Age-Related Disease Therapeutics Summit 2023

Fight Aging! - 16-Jun-2023

Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years

Read more...

Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit

Lifespan.io (LEAF) - 20-Jan-2023

Another reminder of the amount of research, with multiple approaches, about to go into clinical trials

Read more...

Super summary of 3rd Annual Longevity Therapeutics Summit

Lifespan.io (LEAF) - 16-Feb-2021

More and more companies making greater and greater progress - 2021 could be an exciting year

Read more...

Rubedo to first work on lung diseases

Longevity Technology - 20-Jan-2021

Their work will be critical amidst the COVID-19 pandemic - to move into clinical trials soon

Read more...